Therefore, our assay specified an “epithelial” cancer cell presenting the phenotype CD45−/keratins+/vimentinlow/− and a “mesenchymal” cancer cell expressing the CD45−/keratins+/vimentin+ phenotype. The gene discussed is PTPRC; the disease is cancer.